Table 2.
Hypothetical factors | Plausible modes |
---|---|
Th2-driven inflammation | IL-4, IL-5 and IL-13 lead to lower ACE2 expression in respiratory cells |
Eosinophils | Reduction of viral load with subsequent attenuation of COVID-19 |
Inhaled corticosteroids as the main treatment | Downregulation of ACE2 and TMPRSS2 gene expression. Additionally, IL-6 and IL-8 suppression |
TMPRSS2 transmembrane protease serine 2
ACE2 angiotensin converting enzyme 2
Th2 T helper 2
IL interleukin